Antitumor combination including ave8062 and sorafenib

Details Antitumor combination including ave8062 and sorafenib Antitumor combination including ave8062 and sorafenib

A - Human Necessities

61

K

A61K 31/167 (2006.01) A61K 31/4412 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2761146

The invention relates to a pharmaceutical antitumor combination including AVE8062 of formula (I) and sorafenib of formula (II), wherein both of said antitumor agents can be in the form of a base or pharmaceutically acceptable acid salt.

L'invention est relative à une combinaison pharmaceutique antitumorale comprenant I?VE8062 de formule (I)..et le sorafenib de formule (II).. ces deux agents antitumoraux pouvant être sous forme de base ou sous d´un sel d´un acide pharmaceutiquement acceptable.

Affiliated with

Also associated with

Rating

Antitumor combination including ave8062 and sorafenib does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antitumor combination including ave8062 and sorafenib, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antitumor combination including ave8062 and sorafenib will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1878854